Cancer incidence, patterns, and genotype–phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study-Reference-Cited by-同舟云学术

Cancer incidence, patterns, and genotype–phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study

Published:2021-12 Issue:12 Volume:22 Page:1787-1798
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

de Andrade Kelvin César,Khincha Payal P,Hatton Jessica N,Frone Megan N,Wegman-Ostrosky Talia,Mai Phuong L,Best Ana F,Savage Sharon A

Funder

National Cancer Institute Division of Cancer Epidemiology and Genetics

Publisher

Elsevier BV

Subject

Oncology

Reference33 articles.

1. Inherited TP53 mutations and the Li-Fraumeni syndrome;Guha;Cold Spring Harb Perspect Med,2017

2. Li-Fraumeni syndrome;Schneider,1993

3. Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort;Mai;Cancer,2016

4. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study;Villani;Lancet Oncol,2016

5. Cancer screening recommendations for individuals with Li-Fraumeni syndrome;Kratz;Clin Cancer Res,2017

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Generation of two induced pluripotent stem cell lines from patients with Li-Fraumeni Syndrome carrying TP53 mutation;Stem Cell Research;2024-12

2. HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndrome;European Journal of Cancer;2024-11

3. Cell-free DNA from germline TP53 mutation carriers reflect cancer-like fragmentation patterns;Nature Communications;2024-08-27

4. Precision therapy for cancer prevention by targeting carcinogenesis;Molecular Carcinogenesis;2024-08-14

5. Hypoxia-driven lncRNA CTD-2510F5.4: a potential player in hepatocellular carcinoma’s prognostic stratification, cellular behavior, tumor microenvironment, and therapeutic response;Molecular Biology Reports;2024-08-12